- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00842166
Surveillance of Summer Febrile Syndromes of Viral Origin in South of France
August 28, 2014 updated by: Assistance Publique Hopitaux De Marseille
The aim is to document viral etiologies of isolated fevers and inlfuenza-like syndromes during summertime in South of France in order to better understand the role of known vector-borne viruses such as Toscana virus, West Nile virus during seasonal activity of the arthropod vector.
In each of the four cities, a network of general practitioners will be associated in the project to recruit patients who are not hospitalized.
The combined involvement of infectious disease specialists and general practitioner will augment the range of patients (mild disease and sever cases) in the study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Marseille, France
- Service des Maladies Infectieuses et Tropicales de l'Hôpital Nord, AP-HM
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Old: equal to or higher than 5 years Living in the south of France, without voyage abroad in the 2 weeks preceding inclusion Presenting a fever or a syndrome pseudogripal since less than 7 days without diagnostic orientation nor infectious pathology of body,
- Affiliated with a mode of social security
- After obtaining free and informed of the written assent
Exclusion Criteria:
- Subject whose adhesion with the protocol is improbable according to the investigator
- Expectant mother
- Subject taking part in another clinical trial or in period of exclusion of a preceding clinical trial infectious
- Pathology of body requiring a specific treatment
- Discovered after inclusion d' a pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
to document viral etiologies of isolated fevers and inlfuenza-like syndromes during summertime in South of France
Time Frame: 3 years
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Identification and characterization of emergent viruses responsible for estival fever in the south of France
Time Frame: 3years
|
3years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: REMI CHARREL, Assistance Publique Hopitaux de Marseille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (Actual)
July 1, 2011
Study Completion (Actual)
July 1, 2011
Study Registration Dates
First Submitted
February 11, 2009
First Submitted That Met QC Criteria
February 11, 2009
First Posted (Estimate)
February 12, 2009
Study Record Updates
Last Update Posted (Estimate)
August 29, 2014
Last Update Submitted That Met QC Criteria
August 28, 2014
Last Verified
August 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2008 19
- 2008-A00793-52
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Summer Febrile Syndromes of Viral Origin
-
Sorveglianza Epidemiologica Infezioni Fungine Emopatie...CompletedSepsis | Fungal Infection | Neutropenia | Fever | Fever of Unknown Origin | Bacterial Infection | Hematological NeoplasmsItaly
-
Ruhr University of BochumCompletedHealthy Subjects | Complex Regional Pain Syndrome Type I of the Upper Limb | Unilateral Limb Pain of Other OriginGermany
-
Makerere UniversityEuropean and Developing Countries Clinical Trials Partnership (EDCTP)Active, not recruiting
-
National Center for AIDS/STD Control and Prevention...Yunnan Center for Disease Control and Prevention; Yunnan AIDS Care CenterUnknown
-
Hospices Civils de LyonRecruitingAutoimmune Encephalitis Associated With Anti-CAPR2 AntibodiesFrance
-
Gilead SciencesCompletedPre-exposure Prophylaxis for Prevention of HIV InfectionUnited States
-
University of MichiganCompletedHIV Infections | Acceptability of Health CareUnited States
-
Gilead SciencesNational Institute on Drug Abuse (NIDA); National Institute of Allergy and... and other collaboratorsRecruitingPre-Exposure Prophylaxis of HIV InfectionUnited States
-
Gilead SciencesHIV Prevention Trials NetworkRecruitingPre-Exposure Prophylaxis of HIV InfectionUnited States
-
ANRS, Emerging Infectious DiseasesRecruitingMother to Child Transmission of HIVFrance, French Guiana, Guadeloupe, Martinique
Clinical Trials on BLOOD DRAW
-
Abbott Point of CareNot yet recruitingPrecision of Potassium (K) Test in Capillary Whole Blood
-
University Hospital, Strasbourg, FranceNot yet recruitingKidney Transplantation | Humoral Rejection | Kidney Allograft Biopsy | Microvascular Inflammation
-
Turtle Health, Inc.Completed
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Vanderbilt-Ingram Cancer CenterWren Laboratories LLCCompletedMelanomaUnited States
-
National Heart Centre SingaporeDuke-NUS Graduate Medical SchoolRecruiting
-
Duke UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingHematologic MalignancyUnited States
-
University of BonnRecruitingSARS-CoV 2 | COVIDGermany
-
Joseph M. Still Research Foundation, Inc.RecruitingInflammatory Response | Deep Vein Thrombosis | Multi Organ Failure | Nosocomial InfectionUnited States